Launched with unique and distinct combination of Floroquinolone & Nitroimidazole, MEBATIC has been identified as the best solution for treating micro-organisms like anaerobes, aerobes and protozoa that cause diseases like watery diarrhea, dysentery, enteritis, travelers diarrhea, and acute food poisoning.

MEBATIC INFUSION has shown 20 to 25 per cent improved efficacy over the existing therapies. The drug has also been developed with a chemical vector that promotes faster recovery and ensures deeper penetration of antibiotic at the site of infection.

The company made this announcement after the trading hours on 02 February 2010.